Michele P. Zeinieh
Montreal, QC H3A0C7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy.
Journal: Neuro-oncology advances
Published: January 30, 2025
Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function.
Journal: Nature communications
Published: November 14, 2023
Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 01, 2023
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration.
Journal: Cell
Published: April 04, 2022
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
Journal: Cell
Published: July 29, 2020
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.
Journal: Nature communications
Published: November 07, 2018
Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
Journal: Acta neuropathologica
Published: January 20, 2016
Neurotrophins in the regulation of cellular survival and death.
Journal: Handbook of experimental pharmacology
Published: March 27, 2014
p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells.
Journal: The Journal of biological chemistry
Published: February 13, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026